Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies

Background: Whether sex and co-mutations impact prognosis of patients with SMARCA4-mutated (mutSMARCA4) malignancies is not clear. Methods: This cohort included patients from Northern California Kaiser Permanente with next-generation sequencing (NGS) performed from August 2020 to October 2022. We us...

Full description

Bibliographic Details
Main Authors: Minggui Pan, Chen Jiang, Zheyang Zhang, Ninah Achacoso, Aleyda V. Solorzano-Pinto, Pam Tse, Elaine Chung, Jennifer Marie Suga, Sachdev Thomas, Laurel A. Habel
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/10/2665